Title : Prusogliptin (DBPR108) monotherapy in treatment-naive patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 study - Wang_2024_Diabetes.Obes.Metab_26_1321 |
Author(s) : Wang W , Guo X , Zhang C , Ning T , Ma G , Huang Y , Jia R , Zhou D , Cao M , Zhang T , Yao L , Yuan J , Chen L |
Ref : Diabetes Obes Metab , 26 :1321 , 2024 |
Abstract : |
PubMedSearch : Wang_2024_Diabetes.Obes.Metab_26_1321 |
PubMedID: 38221859 |